On paper, 2026 looks like a rare piece of good news for anesthesia. The national Medicare anesthesia conversion factor ticked up to about $20.50 per unit for most physicians, and to roughly $20.60 for those qualifying in advanced alternative payment models, both increases over the 2025 figure of $20.32. After years of cuts, an increase of any size is worth noting.
Look closer, though, and the raise gets complicated. Industry analyses of the 2026 final rule project a net revenue decline for anesthesia once other changes are layered in, and the longer arc of the conversion factor tells an even harder story. This post explains what the 2026 number actually is, why it can still amount to a pay cut, and what groups can control when the rate itself is out of their hands.
The Number Behind the Number: 2026’s Conversion Factor
For 2026, Medicare split the conversion factor in two. Physicians who qualify as participants in advanced alternative payment models receive a slightly higher update, putting the anesthesia conversion factor near $20.60 per unit, while everyone else lands at roughly $20.50, up about 0.9 percent from the 2025 rate of $20.32. The standard, non-anesthesia conversion factor rose more sharply, which underscores a familiar pattern: anesthesia’s time-and-units payment model tends to move differently, and usually more slowly, than the rest of the fee schedule.
A sub-one-percent bump barely keeps pace with a single year of inflation, let alone several. So while the headline is technically an increase, the practical purchasing power of each Medicare anesthesia unit continues to slide.
Why a Raise Can Still Be a Cut
The conversion factor is only one input. The 2026 final rule also carried a practice-expense rebalancing that reduces facility-based reimbursement while raising non-facility payments, and a broad efficiency adjustment that trims RVUs for many non-time-based services. Because so much anesthesia work is time-based, the efficiency adjustment stings less here than in other specialties, but the facility-side practice-expense shift cuts the other way, and independent analyses project a net revenue impact of roughly negative one percent for anesthesia once everything nets out.
Zoom out and the erosion is starker. The anesthesia conversion factor has drifted down for years even in nominal terms, and adjusted for inflation the real value of a Medicare anesthesia unit has fallen dramatically since the end of the last decade. A modest 2026 uptick does not reverse that trend; it slows one year of it. This is the backdrop against which stipends have ballooned and groups have struggled to stay whole on professional billing alone.
The APM Split and What It Signals
The two-tier conversion factor is not an accident. Medicare is deliberately paying qualifying participants in advanced alternative payment models a little more, signaling where the program wants clinicians to move over time. For anesthesia the immediate dollar difference is small, but the direction matters, and groups weighing APM participation should factor the payment differential into that decision rather than treating it as a rounding error.
Quality reporting continues to shape the picture as well. Performance thresholds in the Merit-based Incentive Payment System remain steady in the near term, but the measure set keeps shifting, including the removal of a perioperative temperature-management measure from the anesthesia options, which affects how groups assemble a reportable, defensible quality portfolio.
Protecting Margin When the Rate Won’t
No group can negotiate with the conversion factor, so the only lever left is capture: collecting the full, correct value of every case you already perform. That makes coding precision non-negotiable, because a single missed modifier or miscounted concurrency erases far more than a 0.9 percent update ever added. Tight coding and concurrency oversight and clean claim scrubbing and submission are where a flat fee schedule is quietly won or lost.
The same logic applies downstream. Aggressively working denials and underpayments recovers dollars the rule never touched, and strong reporting and analytics reveal which payers and which case types are underperforming so you can act. Commercial contracts matter even more when Medicare stagnates, and practice management and consulting support can bring the benchmarks that turn a contract renewal into a real raise the fee schedule refuses to give you.
Connecting the Dots
The 2026 conversion factor is a reminder that anesthesia cannot count on Medicare to keep pace with its costs. A tiny nominal increase, undercut by practice-expense changes and years of real erosion, leaves the specialty roughly where it started or slightly behind. What separates groups that thrive from groups that strain is not the rate they are handed but how completely they collect under it, and how hard they push on the commercial contracts and denials they can actually influence.
Final Thought
Treat the 2026 update for what it is: a small nominal gain inside a long-run decline. The groups that protect their margins will be the ones that stop waiting on the fee schedule and instead master the parts of reimbursement they control, from the accuracy of a single unit to the strength of a payer contract. The rate will not save you. Execution will.
If you want to see how much the 2026 changes and your current capture rate are really costing your group, our team can help you model it.